Due to the automated manufacturing execution system there are controls in the manufacturing process to ensure the product met specifications upon release.The reported complaint could not be confirmed, and it could not be definitively determined if the device failed to meet specifications because the product was not returned.The reported event is covered in the device directions for use (dfu).As well, the risk of the reported event is documented in the risk documentation and there are current controls to mitigate the risk of the as reported event.The event reported "vasospasm (after a stent release a slight vasospasm occur, which did not affected on the blood flow)".Additional information provided by the customer indicated that they believed the reported issue was caused by device re-sheathing, and the manipulation of the device in middle cerebral artery was the reason for the vasospasm.Based upon medical review, the harm observed in this complaint is anticipated in nature as per the device risk assessment.An assignable cause of procedural factors will be assigned to the reported 'patient vasospasm serious' as the issue is associated with a product that meets stryker design and manufacture specifications and was used in according with the dfu but due to procedural and/or anatomical factors during use, the product performance was limited.
|